Skip to main content
Erschienen in: Archives of Virology 1/2017

11.07.2016 | Original Article

A naturally truncated NS1 protein of influenza A virus impairs its interferon-antagonizing activity and thereby confers attenuation in vitro

verfasst von: Jihye Lee, Ji Hoon Park, Ji-Young Min

Erschienen in: Archives of Virology | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

The non-structural protein of influenza A virus (NS1A protein) is a multifunctional protein that antagonizes host antiviral responses and contributes to efficient viral replication during infection. However, most of its functions have been elucidated by generating recombinant viruses expressing mutated NS1 proteins that do not exist in nature. Recently, the novel H3N8 A/Equine/Kyonggi/SA1/2011 (KG11) influenza virus was isolated in Korea from horses showing respiratory disease symptoms. KG11 virus contains a naturally truncated NS gene segment with the truncation in the NS1A coding region, resulting in truncation of the effector domain of the NS1A protein. Using this KG11 virus, we investigated the role of truncated NS1A protein in the virus life cycle and its effect on host immune responses were compared to the A/Equine/Miami/1/1963 H3N8 (MA63) virus, which encodes a full-length NS1A protein. The replication of KG11 virus was attenuated by 2 logs in multiple-cycle growth, and its plaque size was significantly smaller than that of the MA63 virus. To understand the attenuation of KG11 virus, we evaluated the level of activation in Akt and interferon regulatory factor 3 (IRF-3) pathways and measured the induction of downstream genes. Our results showed that the activation of Akt was reduced, whereas phosphorylation of IRF-3 was increased in cells infected with KG11 virus when compared to MA63-virus-infected cells. We also determined that the expression of antiviral and pro-inflammatory genes was significantly increased. Taken together, these results revealed that the KG11 virus expressing the naturally truncated NS1A protein impairs the inhibition of host antiviral responses, thereby resulting in the attenuation of viral replication.
Literatur
1.
Zurück zum Zitat Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783–801CrossRefPubMed Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783–801CrossRefPubMed
2.
Zurück zum Zitat Bornholdt ZA, Prasad BV (2006) X-ray structure of influenza virus NS1 effector domain. Nat Struct Mol Biol 13:559–560CrossRefPubMed Bornholdt ZA, Prasad BV (2006) X-ray structure of influenza virus NS1 effector domain. Nat Struct Mol Biol 13:559–560CrossRefPubMed
3.
Zurück zum Zitat Choi EH, Song MS, Park SJ, Pascua PN, Baek YH, Kwon HI, Kim EH, Kim S, Jang HK, Poo H, Kim CJ, Choi YK (2015) Development of a dual-protective live attenuated vaccine against H5N1 and H9N2 avian influenza viruses by modifying the NS1 gene. Arch Virol 160:1729–1740CrossRefPubMed Choi EH, Song MS, Park SJ, Pascua PN, Baek YH, Kwon HI, Kim EH, Kim S, Jang HK, Poo H, Kim CJ, Choi YK (2015) Development of a dual-protective live attenuated vaccine against H5N1 and H9N2 avian influenza viruses by modifying the NS1 gene. Arch Virol 160:1729–1740CrossRefPubMed
4.
Zurück zum Zitat Cullinane A, Newton JR (2013) Equine influenza–a global perspective. Vet Microbiol 167:205–214CrossRefPubMed Cullinane A, Newton JR (2013) Equine influenza–a global perspective. Vet Microbiol 167:205–214CrossRefPubMed
5.
Zurück zum Zitat Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, Maniatis T (2003) IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4:491–496CrossRefPubMed Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, Maniatis T (2003) IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4:491–496CrossRefPubMed
6.
Zurück zum Zitat Geiss GK, Salvatore M, Tumpey TM, Carter VS, Wang X, Basler CF, Taubenberger JK, Bumgarner RE, Palese P, Katze MG, Garcia-Sastre A (2002) Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc Natl Acad Sci USA 99:10736–10741CrossRefPubMedPubMedCentral Geiss GK, Salvatore M, Tumpey TM, Carter VS, Wang X, Basler CF, Taubenberger JK, Bumgarner RE, Palese P, Katze MG, Garcia-Sastre A (2002) Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc Natl Acad Sci USA 99:10736–10741CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Hale BG, Jackson D, Chen YH, Lamb RA, Randall RE (2006) Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling. Proc Natl Acad Sci USA 103:14194–14199CrossRefPubMedPubMedCentral Hale BG, Jackson D, Chen YH, Lamb RA, Randall RE (2006) Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling. Proc Natl Acad Sci USA 103:14194–14199CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Hale BG, Barclay WS, Randall RE, Russell RJ (2008) Structure of an avian influenza A virus NS1 protein effector domain. Virology 378:1–5CrossRefPubMed Hale BG, Barclay WS, Randall RE, Russell RJ (2008) Structure of an avian influenza A virus NS1 protein effector domain. Virology 378:1–5CrossRefPubMed
9.
Zurück zum Zitat Hale BG, Batty IH, Downes CP, Randall RE (2008) Binding of influenza A virus NS1 protein to the inter-SH2 domain of p85 suggests a novel mechanism for phosphoinositide 3-kinase activation. J Biol Chem 283:1372–1380CrossRefPubMed Hale BG, Batty IH, Downes CP, Randall RE (2008) Binding of influenza A virus NS1 protein to the inter-SH2 domain of p85 suggests a novel mechanism for phosphoinositide 3-kinase activation. J Biol Chem 283:1372–1380CrossRefPubMed
10.
Zurück zum Zitat Hatada E, Fukuda R (1992) Binding of influenza A virus NS1 protein to dsRNA in vitro. J Gen Virol 73(Pt 12):3325–3329CrossRefPubMed Hatada E, Fukuda R (1992) Binding of influenza A virus NS1 protein to dsRNA in vitro. J Gen Virol 73(Pt 12):3325–3329CrossRefPubMed
11.
Zurück zum Zitat Hawkins PT, Anderson KE, Davidson K, Stephens LR (2006) Signalling through Class I PI3Ks in mammalian cells. Biochem Soc Trans 34:647–662CrossRefPubMed Hawkins PT, Anderson KE, Davidson K, Stephens LR (2006) Signalling through Class I PI3Ks in mammalian cells. Biochem Soc Trans 34:647–662CrossRefPubMed
12.
Zurück zum Zitat Hayman A, Comely S, Lackenby A, Murphy S, McCauley J, Goodbourn S, Barclay W (2006) Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway. Virology 347:52–64CrossRefPubMed Hayman A, Comely S, Lackenby A, Murphy S, McCauley J, Goodbourn S, Barclay W (2006) Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway. Virology 347:52–64CrossRefPubMed
13.
Zurück zum Zitat Horimoto T, Kawaoka Y (2005) Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol 3:591–600CrossRefPubMed Horimoto T, Kawaoka Y (2005) Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol 3:591–600CrossRefPubMed
14.
Zurück zum Zitat Juang YT, Lowther W, Kellum M, Au WC, Lin R, Hiscott J, Pitha PM (1998) Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3. Proc Natl Acad Sci USA 95:9837–9842CrossRefPubMedPubMedCentral Juang YT, Lowther W, Kellum M, Au WC, Lin R, Hiscott J, Pitha PM (1998) Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3. Proc Natl Acad Sci USA 95:9837–9842CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Kappes MA, Sandbulte MR, Platt R, Wang C, Lager KM, Henningson JN, Lorusso A, Vincent AL, Loving CL, Roth JA, Kehrli ME Jr (2012) Vaccination with NS1-truncated H3N2 swine influenza virus primes T cells and confers cross-protection against an H1N1 heterosubtypic challenge in pigs. Vaccine 30:280–288CrossRefPubMed Kappes MA, Sandbulte MR, Platt R, Wang C, Lager KM, Henningson JN, Lorusso A, Vincent AL, Loving CL, Roth JA, Kehrli ME Jr (2012) Vaccination with NS1-truncated H3N2 swine influenza virus primes T cells and confers cross-protection against an H1N1 heterosubtypic challenge in pigs. Vaccine 30:280–288CrossRefPubMed
16.
Zurück zum Zitat Kochs G, Garcia-Sastre A, Martinez-Sobrido L (2007) Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol 81:7011–7021CrossRefPubMedPubMedCentral Kochs G, Garcia-Sastre A, Martinez-Sobrido L (2007) Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol 81:7011–7021CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Li Y, Anderson DH, Liu Q, Zhou Y (2008) Mechanism of influenza A virus NS1 protein interaction with the p85beta, but not the p85alpha, subunit of phosphatidylinositol 3-kinase (PI3 K) and up-regulation of PI3 K activity. J Biol Chem 283:23397–23409CrossRefPubMed Li Y, Anderson DH, Liu Q, Zhou Y (2008) Mechanism of influenza A virus NS1 protein interaction with the p85beta, but not the p85alpha, subunit of phosphatidylinositol 3-kinase (PI3 K) and up-regulation of PI3 K activity. J Biol Chem 283:23397–23409CrossRefPubMed
18.
Zurück zum Zitat Lin D, Lan J, Zhang Z (2007) Structure and function of the NS1 protein of influenza A virus. Acta Biochim Biophys Sin 39:155–162CrossRefPubMed Lin D, Lan J, Zhang Z (2007) Structure and function of the NS1 protein of influenza A virus. Acta Biochim Biophys Sin 39:155–162CrossRefPubMed
19.
Zurück zum Zitat Ludwig S, Wang X, Ehrhardt C, Zheng H, Donelan N, Planz O, Pleschka S, Garcia-Sastre A, Heins G, Wolff T (2002) The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors. J Virol 76:11166–11171CrossRefPubMedPubMedCentral Ludwig S, Wang X, Ehrhardt C, Zheng H, Donelan N, Planz O, Pleschka S, Garcia-Sastre A, Heins G, Wolff T (2002) The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors. J Virol 76:11166–11171CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Luytjes W, Krystal M, Enami M, Parvin JD, Palese P (1989) Amplification, expression, and packaging of foreign gene by influenza virus. Cell 59:1107–1113CrossRefPubMed Luytjes W, Krystal M, Enami M, Parvin JD, Palese P (1989) Amplification, expression, and packaging of foreign gene by influenza virus. Cell 59:1107–1113CrossRefPubMed
21.
Zurück zum Zitat Na W, Kang B, Kim HI, Hong M, Park SJ, Jeoung HY, An DJ, Moon H, Kim JK, Song D (2014) Isolation and genetic characterization of naturally NS-truncated H3N8 equine influenza virus in South Korea. Epidemiol Infect 142:759–766CrossRefPubMed Na W, Kang B, Kim HI, Hong M, Park SJ, Jeoung HY, An DJ, Moon H, Kim JK, Song D (2014) Isolation and genetic characterization of naturally NS-truncated H3N8 equine influenza virus in South Korea. Epidemiol Infect 142:759–766CrossRefPubMed
22.
Zurück zum Zitat Nemeroff ME, Qian XY, Krug RM (1995) The influenza virus NS1 protein forms multimers in vitro and in vivo. Virology 212:422–428CrossRefPubMed Nemeroff ME, Qian XY, Krug RM (1995) The influenza virus NS1 protein forms multimers in vitro and in vivo. Virology 212:422–428CrossRefPubMed
23.
Zurück zum Zitat Nemeroff ME, Barabino SM, Li Y, Keller W, Krug RM (1998) Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3′end formation of cellular pre-mRNAs. Mol cell 1:991–1000CrossRefPubMed Nemeroff ME, Barabino SM, Li Y, Keller W, Krug RM (1998) Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3′end formation of cellular pre-mRNAs. Mol cell 1:991–1000CrossRefPubMed
24.
Zurück zum Zitat Noah DL, Twu KY, Krug RM (2003) Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3′ end processing of cellular pre-mRNAS. Virology 307:386–395CrossRefPubMed Noah DL, Twu KY, Krug RM (2003) Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3′ end processing of cellular pre-mRNAS. Virology 307:386–395CrossRefPubMed
25.
Zurück zum Zitat Noah DL, Krug RM (2005) Influenza virus virulence and its molecular determinants. Adv Virus Res 65:121–145CrossRefPubMed Noah DL, Krug RM (2005) Influenza virus virulence and its molecular determinants. Adv Virus Res 65:121–145CrossRefPubMed
26.
Zurück zum Zitat Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, Weber F, Reis e Sousa C (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314:997–1001CrossRefPubMed Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, Weber F, Reis e Sousa C (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314:997–1001CrossRefPubMed
27.
Zurück zum Zitat Richt JA, Garcia-Sastre A (2009) Attenuated influenza virus vaccines with modified NS1 proteins. Curr Top Microbiol Immunol 333:177–195PubMed Richt JA, Garcia-Sastre A (2009) Attenuated influenza virus vaccines with modified NS1 proteins. Curr Top Microbiol Immunol 333:177–195PubMed
28.
Zurück zum Zitat Sato M, Tanaka N, Hata N, Oda E, Taniguchi T (1998) Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-beta gene. FEBS Lett 425:112–116CrossRefPubMed Sato M, Tanaka N, Hata N, Oda E, Taniguchi T (1998) Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-beta gene. FEBS Lett 425:112–116CrossRefPubMed
29.
Zurück zum Zitat Sharma S, tenOever BR, Grandvaux N, Zhou GP, Lin R, Hiscott J (2003) Triggering the interferon antiviral response through an IKK-related pathway. Science 300:1148–1151CrossRefPubMed Sharma S, tenOever BR, Grandvaux N, Zhou GP, Lin R, Hiscott J (2003) Triggering the interferon antiviral response through an IKK-related pathway. Science 300:1148–1151CrossRefPubMed
30.
Zurück zum Zitat Shi S, Chen S, Han W, Wu B, Zhang X, Tang Y, Wang X, Zhu Y, Peng D, Liu X (2016) Cross-clade protective immune responses of NS1-truncated live attenuated H5N1 avian influenza vaccines. Vaccine 34:350–357CrossRefPubMed Shi S, Chen S, Han W, Wu B, Zhang X, Tang Y, Wang X, Zhu Y, Peng D, Liu X (2016) Cross-clade protective immune responses of NS1-truncated live attenuated H5N1 avian influenza vaccines. Vaccine 34:350–357CrossRefPubMed
31.
Zurück zum Zitat Shin YK, Li Y, Liu Q, Anderson DH, Babiuk LA, Zhou Y (2007) SH3 binding motif 1 in influenza A virus NS1 protein is essential for PI3 K/Akt signaling pathway activation. J Virol 81:12730–12739CrossRefPubMedPubMedCentral Shin YK, Li Y, Liu Q, Anderson DH, Babiuk LA, Zhou Y (2007) SH3 binding motif 1 in influenza A virus NS1 protein is essential for PI3 K/Akt signaling pathway activation. J Virol 81:12730–12739CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Talbot HK, Poehling KA, Williams JV, Zhu Y, Chen Q, McNabb P, Edwards KM, Griffin MR (2009) Influenza in older adults: impact of vaccination of school children. Vaccine 27:1923–1927CrossRefPubMed Talbot HK, Poehling KA, Williams JV, Zhu Y, Chen Q, McNabb P, Edwards KM, Griffin MR (2009) Influenza in older adults: impact of vaccination of school children. Vaccine 27:1923–1927CrossRefPubMed
34.
Zurück zum Zitat Talon J, Horvath CM, Polley R, Basler CF, Muster T, Palese P, Garcia-Sastre A (2000) Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol 74:7989–7996CrossRefPubMedPubMedCentral Talon J, Horvath CM, Polley R, Basler CF, Muster T, Palese P, Garcia-Sastre A (2000) Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol 74:7989–7996CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Vincent AL, Ma W, Lager KM, Richt JA, Janke BH, Sandbulte MR, Gauger PC, Loving CL, Webby RJ, Garcia-Sastre A (2012) Live attenuated influenza vaccine provides superior protection from heterologous infection in pigs with maternal antibodies without inducing vaccine-associated enhanced respiratory disease. J Virol 86:10597–10605CrossRefPubMedPubMedCentral Vincent AL, Ma W, Lager KM, Richt JA, Janke BH, Sandbulte MR, Gauger PC, Loving CL, Webby RJ, Garcia-Sastre A (2012) Live attenuated influenza vaccine provides superior protection from heterologous infection in pigs with maternal antibodies without inducing vaccine-associated enhanced respiratory disease. J Virol 86:10597–10605CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Wang X, Basler CF, Williams BR, Silverman RH, Palese P, Garcia-Sastre A (2002) Functional replacement of the carboxy-terminal two-thirds of the influenza A virus NS1 protein with short heterologous dimerization domains. J Virol 76:12951–12962CrossRefPubMedPubMedCentral Wang X, Basler CF, Williams BR, Silverman RH, Palese P, Garcia-Sastre A (2002) Functional replacement of the carboxy-terminal two-thirds of the influenza A virus NS1 protein with short heterologous dimerization domains. J Virol 76:12951–12962CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Wathelet MG, Lin CH, Parekh BS, Ronco LV, Howley PM, Maniatis T (1998) Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol cell 1:507–518CrossRefPubMed Wathelet MG, Lin CH, Parekh BS, Ronco LV, Howley PM, Maniatis T (1998) Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol cell 1:507–518CrossRefPubMed
38.
Metadaten
Titel
A naturally truncated NS1 protein of influenza A virus impairs its interferon-antagonizing activity and thereby confers attenuation in vitro
verfasst von
Jihye Lee
Ji Hoon Park
Ji-Young Min
Publikationsdatum
11.07.2016
Verlag
Springer Vienna
Erschienen in
Archives of Virology / Ausgabe 1/2017
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-016-2966-9

Weitere Artikel der Ausgabe 1/2017

Archives of Virology 1/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.